MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-12-2025
TherapeuticsMD ROCE Ratio 2011-2026 | TXMD
Annual ROCE Ratio TherapeuticsMD
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -29.1 | 3.39 | 85.0 | -127.11 | -70.99 | -76.19 | -59.76 | -70.79 | -135.09 | -111.68 | -47.18 | -700.25 | 317.04 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 317.04 | -700.25 | -78.67 |
Quarterly ROCE Ratio TherapeuticsMD
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 30.08 | 60.16 | 117.15 | 99.79 | 137.59 | 177.11 | 191.8 | 487.99 | 421.91 | 331.84 | 225.28 | -123.34 | -107.77 | -100.01 | -84.69 | -50.15 | -70.27 | -77.68 | -77.48 | -64.81 | -76.23 | -67.53 | -63.44 | -43.07 | -62.78 | -71.07 | -72.44 | -52.8 | -83.73 | -94.94 | -121.52 | -107.32 | -144.21 | -150.16 | -129.53 | -77.96 | -91.19 | -67.54 | -55.23 | -32.54 | -202.11 | -358.46 | -520.54 | -466.29 | -381.93 | -127.98 | 105.75 | 190.82 | 84.37 | 61.38 | 45.06 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 487.99 | -520.54 | -33.54 |
ROCE Ratio of other stocks in the Drug manufacturers industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aerie Pharmaceuticals
AERI
|
267.43 | - | - | $ 754 M |  USA |
 |
AcelRx Pharmaceuticals
ACRX
|
-190.63 | - | 7.5 % | $ 6.35 M | USA |
 |
Catalent
CTLT
|
-20.78 | - | - | $ 11.5 B | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
3101.1 | - | 0.86 % | $ 117 M | USA |
 |
DURECT Corporation
DRRX
|
-249.5 | - | - | $ 50.1 M | USA |
 |
Canopy Growth Corporation
CGC
|
-24.04 | $ 1.11 | 4.27 % | $ 119 M |  Canada |
 |
Endo International plc
ENDP
|
7.34 | - | - | $ 28.9 M |  Irlanda |
 |
Agile Therapeutics
AGRX
|
121.85 | - | 10.11 % | $ 58.2 M | USA |
 |
Evoke Pharma
EVOK
|
-184.26 | - | - | $ 36.6 M | USA |
 |
Alimera Sciences
ALIM
|
-4.18 | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
-10.43 | $ 2.66 | 2.47 % | $ 1.38 B | Canada |
 |
Evolus
EOLS
|
141.36 | $ 5.19 | 25.54 % | $ 335 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-57.41 | - | - | $ 2.06 B |  France |
 |
Jupiter Wellness
JUPW
|
-116.71 | - | - | $ 33.6 M | USA |
 |
China Pharma Holdings
CPHI
|
-59.23 | $ 0.58 | 2.89 % | $ 10.1 M |  China |
 |
Cumberland Pharmaceuticals
CPIX
|
-8.06 | $ 4.18 | -8.73 % | $ 58.8 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-39.6 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
-85.61 | - | 2.45 % | $ 38.1 M | Canada |
 |
Harrow Health
HROW
|
58.18 | $ 39.81 | 3.11 % | $ 1.46 B | USA |
 |
Neoleukin Therapeutics
NLTX
|
-29.88 | - | - | $ 193 M | Canada |
 |
Aurora Cannabis
ACB
|
-23.09 | $ 3.67 | 5.32 % | $ 86.3 M | Canada |
 |
Athenex
ATNX
|
1076.15 | - | -23.39 % | $ 1.76 M | USA |
 |
Emergent BioSolutions
EBS
|
-111.87 | $ 8.69 | -2.47 % | $ 445 M | USA |
 |
ProPhase Labs
PRPH
|
32.97 | - | - | $ 5.07 M | USA |
 |
Assertio Holdings
ASRT
|
-176.47 | $ 12.24 | 2.9 % | $ 869 M | USA |
 |
Radius Health
RDUS
|
21.53 | - | - | $ 1.42 B | USA |
 |
Bausch Health Companies
BHC
|
-94.23 | $ 5.63 | -1.66 % | $ 2.05 B | Canada |
 |
Lannett Company
LCI
|
70.21 | - | 1.15 % | $ 7.11 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
34.66 | - | -39.89 % | $ 27.7 M | USA |
 |
Organogenesis Holdings
ORGO
|
-0.49 | $ 2.96 | 3.1 % | $ 390 M | USA |
 |
OrganiGram Holdings
OGI
|
-35.84 | $ 1.41 | 2.55 % | $ 402 M | Canada |
 |
Rockwell Medical
RMTI
|
-31.33 | $ 0.9 | 0.08 % | $ 21 M | USA |
 |
Perrigo Company plc
PRGO
|
-14.92 | $ 11.61 | 1.98 % | $ 1.61 B | USA |
 |
Sundial Growers
SNDL
|
-68.48 | $ 1.55 | 1.31 % | $ 3.37 M | Canada |
 |
Veru
VERU
|
-114.23 | $ 2.67 | 5.95 % | $ 360 M | USA |
 |
Viatris
VTRS
|
3.74 | $ 14.7 | -1.31 % | $ 17.6 B | USA |
 |
Pacira BioSciences
PCRX
|
-9.43 | $ 22.6 | 2.26 % | $ 1.05 B | USA |
 |
PetIQ
PETQ
|
5.46 | - | 1.64 % | $ 400 M | USA |
 |
OptiNose
OPTN
|
26.27 | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
-114.37 | - | -27.8 % | $ 2.56 M | USA |
 |
Recro Pharma
REPH
|
-6.09 | - | -4.76 % | $ 65.3 M | USA |
 |
Relmada Therapeutics
RLMD
|
-121.49 | $ 4.77 | 2.14 % | $ 144 M | USA |
 |
cbdMD
YCBD
|
-235.96 | $ 0.8 | 3.77 % | $ 3.45 M | USA |
 |
SCYNEXIS
SCYX
|
99.6 | $ 0.77 | 2.75 % | $ 36.8 M | USA |
 |
Solid Biosciences
SLDB
|
-81.9 | $ 6.15 | 3.19 % | $ 251 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-84.11 | $ 2.69 | -2.18 % | $ 3.34 M | USA |
 |
Tricida
TCDA
|
-70162.39 | - | - | $ 3.25 M | USA |
 |
Tilray
TLRY
|
-41.31 | $ 7.51 | 2.04 % | $ 4.64 B | Canada |
 |
Zynerba Pharmaceuticals
ZYNE
|
-76.25 | - | - | $ 55.5 M | USA |